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Abstract
Aims/hypothesis Evaluation of the association of 31 common
singlenucleotidepolymorphisms(SNPs)withfastingglucose,
fasting insulin, HOMA-beta cell function (HOMA-β),
HOMA-insulin resistance (HOMA-IR) and type 2 diabetes
in the Indian population.
Methods We genotyped 3,089 sib pairs recruited in the
Indian Migration Study from four cities in India (Lucknow,
Nagpur, Hyderabad and Bangalore) for 31 SNPs in 24
genes previously associated with type 2 diabetes in
European populations. We conducted within-sib-pair analysis
for type 2 diabetes and its related quantitative traits.
Results The risk-allele frequencies of all the SNPs were
comparable with those reported in western populations. We
demonstrated significant associations of CXCR4
(rs932206), CDKAL1 (rs7756992) and TCF7L2
(rs7903146, rs12255372) with fasting glucose, with β
values of 0.007 (p=0.05), 0.01 (p=0.01), 0.007 (p=0.05),
Members of the Indian Migration Study Group are shown in the
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DOI 10.1007/s00125-011-2355-60.01 (p=0.003) and 0.08 (p=0.01), respectively. Variants in
NOTCH2 (rs10923931), TCF-2 (also known as HNF1B)
(rs757210), ADAM30 (rs2641348) and CDKN2A/B
(rs10811661) significantly predicted fasting insulin, with
β values of −0.06 (p=0.04), 0.05 (p=0.05), −0.08 (p=0.01)
and −0.08 (p=0.02), respectively. For HOMA-IR, we
detected associations with TCF-2, ADAM30 and
CDKN2A/B,w i t hβ values of 0.05 (p=0.04), −0.07 (p=
0.03) and −0.08 (p=0.02), respectively. We also found
significant associations of ADAM30 (β=−0.05; p=0.01)
and CDKN2A/B (β=−0.05; p=0.03) with HOMA-β.
THADA variant (rs7578597) was associated with type 2
diabetes (OR 1.5; 95% CI 1.04, 2.22; p=0.03).
Conclusions/interpretation We validated the association of
seven established loci with intermediate traits related to
type 2 diabetes in an Indian population using a design
resistant to population stratification.
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Introduction
Type 2 diabetes is an outcome of chronic hyperglycaemia
and is clinically characterised by impaired insulin secretion
and insulin resistance [1, 2]. With 51 million individuals
with type 2 diabetes [3], India could easily become an
epicentre for research into the detection of common
biological mechanisms through the genomics of diabetes
and its related quantitative traits and their pathological
phenotypic extensions. Several genome-wide association
studies (GWASs) have confirmed associations of at least 38
common genetic variations with type 2 diabetes and related
intermediate traits and many more are anticipated with
growing sample sizes and better array performance [4–6].
In the light of the above discoveries, it is interesting to
investigate whether the top GWAS signals in European
populations are also associated with diabetes in populations
of different ancestry, such as South Asians [7]. Therefore,
validation of single nucleotide polymorphisms (SNPs) from
different loci identified through GWASs is now an
important step towards genomic medicine.
In India most genetic studies of type 2 diabetes
published to date have used hospital-based case–control
designs for either establishing candidate genes in the
metabolic pathways of interest [8, 9] or validating GWAS
findings [10–13]. Further, the studies on quantitative traits
of type 2 diabetes in India are few [14, 15] and have
investigated a limited number of SNPs. For instance,
Chauhan et al. [15] have recently validated two loci
(TCF7L2 and PPARG) associated with HOMA-beta cell
function (HOMA-β) from eight loci tested in 2,500 control
participants from the Indo-European linguistic group of
India.
A high level of population stratification and ecological
diversity has complicated genetic epidemiological studies
in India. It has been estimated that the population
differentiation between two neighbouring populations in
India may be as large as that between northern and southern
Europeans (average fixation index [FST] value of 0.0109
compared with FST=0.003 for northern and southern
Europeans) [16]. Moreover, the endogamous structure of
the Indian population has maintained a high level of linkage
disequilibrium (LD) because of ancestral founder effects
[16]. It has been suggested that genetic predisposition to
diabetes may differ in Indians compared with Europeans
[15]; however, in view of the endogamous structure and the
high possibility of population stratification, these results
need to be interpreted with caution.
As very few studies in India have tested the association
of type 2 diabetes SNPs with related quantitative traits, we
conducted the present study to evaluate the relationships
between 31 GWAS-confirmed type 2 diabetes SNPs from
24 genes with type 2 diabetes and four available interme-
diate traits: fasting glucose; fasting insulin; HOMA-insulin
resistance (HOMA-IR); and HOMA-β.W eu s e da
population-based cohort of 3,089 sib pairs (2,528 for
quantitative traits and 561 for type 2 diabetes) drawn from
four cities across India, a design resistant to population
stratification as comparisons are made within sib pairs.
Methods
Study population The study included individuals recruited
to the population-based Indian Migration Study (IMS)
conducted during 2005–2007 in factories located in four
cities (Lucknow, Nagpur, Hyderabad and Bangalore) of
India. Briefly, each migrant worker and spouse were asked
to invite one non-migrant full sibling of the same sex and
closest to them in age still residing in their rural place of
origin to take part in the study. This strategy resulted in
rural-dwelling sibs being drawn from 20 of the 28 states in
India, reflecting the migration patterns of the factory
workforce and their spouses (for details see the Electronic
supplementary material [ESM text]). Phenotypic information
was available for 7,067 participants, of whom 6,780
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collected after receiving informed consent from the study
participants. Ethical approval was obtained from the ethics
committee of the All India Institute of Medical Sciences
(AIIMS), New Delhi, India (reference number A-60/4/8/
2004).
Biochemical phenotypes After the separation of plasma and
serum, samples were transported monthly to AIIMS for the
biochemical assays. Fasting plasma glucose was measured
on the day of blood collection by local laboratories at each
site using the GOD-PAP method and RANDOX kits
(Randox Laboratories, Crumlin, UK) [17]. Fasting insulin
was assayed in serum samples by the ELISA method, as a
solid-phase two-site enzyme immunoassay, using kits from
MERCODIA (Mercodia AB, Sylveniusgatan, Uppsala,
Sweden) [18]. The quality of local assays was monitored
by AIIMS, and checked regularly with external standards
and internal duplicate assays. For quality assurance
purposes, the Cardiac Biochemistry Laboratory, AIIMS,
is part of the UK National External Quality Assessment
(www.ukneqas.org.uk/). HOMA-IR and HOMA-β scores
were calculated using standard equations [19]. Participants
with fasting glucose ≥7 mmol/l or already diagnosed with
diabetes (with or without medication) were classified as
type 2 diabetes.
Genotyping and quality control Genomic DNAwas isolated
from all samples using the saltprecipitation method and DNA
samples were plated in 96-deep-well storage plates at a
uniform concentration of 10 ng/λ at the Centre for Cellular
and Molecular Biology, Hyderabad, India. Each plate
included eight repeat samples (∼10%) as a quality
control measure. We used the Sequenom Mass ARRAY
technology to genotype 31 type-2-diabetes-related SNPs
from 24 loci, which were discovered in various GWASs
[20–23] as part of a common multiplex pool. The study
was proposed in 2007 and started in 2008; therefore the
SNPs included in the genotyping panel are part of GWAS
results published up to that time. We also included some
SNPs with p values >1×10
−7 to validate their associations
in the Indian population. The genotyping success rate was
>95% and results of duplicate samples had >97%
concordance. The final analysis for quantitative traits
was done on 2,528 sib pairs (5,056 individuals) because
2,011 of the 7,067 individuals with phenotypic informa-
tion were excluded from the analysis (i.e. 301 pairs [602
individuals] had genotyping data for fewer than 50% of
the 31 genotyped SNPs; 136 pairs [272 individuals] were
not true siblings; 15 individuals were singletons; and 561
pairs [1,122 individuals] were concordant/discordant for
type 2 diabetes). Type 2 diabetes as a binary trait was
investigated using data from 561 pairs (1,122 individuals).
Sample size and power calculation Given a sample size of
2,528 sib pairs and minor allele frequency (MAF)=9–
48%, our study had ≥80% power to detect a quantitative
trait locus explaining 0.7% of genetic variation at α=
0.05 and 1.5% of genetic variation at α=0.001, for each of
the tested traits. This was plausible in the context of
genetic effect estimates observed for quantitative traits in
European populations, which range from r
2<0.001 to r
2=
0.013 (β range 0.008 to −0.28, ESM Table 1). For type 2
diabetes as a binary outcome, based on the 561 sib pairs
(487 discordant and 74 concordant pairs), we had 20%
power to detect an OR of 1.17 (the average European
effect size) given MAF of 23% (average MAF in this
study) (ESM Tables 2 and 3). The above calculations were
performed using the Genetic Power Calculator (http://
ibgwww.colorado.edu/∼pshaun/gpc/;o p t i o no f‘QTL associ-
ation for sibships’)[ 24] for quantitative traits, and QUANTO
1.1 (http://hydra.usc.edu/gxe) for type 2 diabetes as a binary
trait (using the case–sibling option).
Statistical analyses Genotype frequencies were calculated in
unrelated individuals residing in an urban location (a single
randomly chosen member from each family) (n=2,148) and
tested for departure from Hardy–Weinberg equilibrium using
the exact test implemented in PLINK (version 0.99p; http://
pngu.mgh.harvard.edu/∼purcell/PLINK)[ 25].
Association analysis was carried out using the
orthogonal family-based model of Fulker et al. [26].
This is a mixed regression model in which the genetic
effect is decomposed into fixed between- and within-
family effects, with inference performed on the within-
family effect. Shared environmental and residual genetic
effects within families are modelled as a random effect.
We fitted models in STATA (version 10) as the QTDT
software [27], widely used for the Fulker model, is limited
to analysis of quantitative traits. For drawing inferences,
we have used the results after adjustment for BMI because
adjustment with this covariate has reduced the residual
variance in the regression model and provided more
significant findings in comparison with the unadjusted
model. In the ESM text we describe additional analyses of
population structure and corresponding adjustments to
association tests. Although the corrected overall critical
p value using a false-discovery rate for each trait is equal
to 0.002 [28], we have drawn inferences on the basis of
uncorrected p values because there was strong prior
evidence of associations of all the examined SNPs with
type 2 diabetes [20–23].
Assuming additive models, we restricted the analysis
to full sib pairs (n=2,528 pairs) after removing the pairs
concordant/discordant for type 2 diabetes (n=561 pairs);
for each SNP the major allele was the reference, and an
effect estimate was calculated per copy of the minor allele.
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formed z scores of quantitative phenotypes were tested
after including age, sex and location (urban or rural) as
covariates. We also tested separately for interaction
between- and within-families genetic effect and age, sex
and location (rural/urban) as effect modifiers in the models
for quantitative traits.
For association analysis with the discrete trait of type 2
diabetes, we used a mixed logistic regression model using
the same Fulker’s decomposition of genotypes on 561 sib
pairs (see ESM Table 4).
Results
Estimates of MAFs for 29 of the tested SNPs were
available from the HapMap-GIH (Gujarati Indians in
Houston) population (http://hapmap.ncbi.nlm.nih.gov) and
were found to be similar to those in the study sample (ESM
Table 2). The summary characteristics of the study
participants are given in Table 1 (see also ESM Table 4).
As age, sex and location (urban/rural) were associated with
type 2 diabetes [29], these covariates were included in
further association models.
We found that 7 of the 31 SNPs were associated with at
least one of the four continuous traits related to type 2
diabetes after adjusting for BMI (Table 2; see also ESM
Table 5 for unadjusted results).
Associationanalysiswithfastinginsulinand HOMA-IR Using
within family-based approach, we found a variant of
ADAM30 (ADAM metallopeptidase domain 30,
rs2641348, G allele) was associated with lower levels of
fasting insulin (β=−0.08, 95% CI −0.02, −0.02, p=0.009)
and HOMA-IR (β=−0.07, 95% CI −0.13, −0.006, p=
0.03). Similarly, we also found an association of the
CDKN2A/B locus (rs10811661, C allele) with lower levels
of fasting insulin (β=−0.09, 95% CI −0.16, −0.02, p=
0.02) and HOMA-IR (β=−0.09, 95% CI −0.16, −0.02, p=
0.02). Further, the T allele at rs10923931 variant in Notch
homologue 2 (NOTCH2) showed a decreased level of
fasting insulin (β=−0.06, 95% CI −0.12, −0.001, p=0.04),
whereas, TCF-2 (also known as HNF1B) (rs757210, A
allele) was associated with higher levels of fasting insulin
(β=0.05, 95% CI −0.001, 0.11, p=0.05) and HOMA-IR
(β=0.05, 95% CI 0.003, 0.11, p=0.04). We observed a
strong LD (r
2>0.80; range 0.81–0.92) between ADAM30
and NOTCH2 in the study population (ESM Table 6).
Association analysis with fasting glucose and HOMA-β We
observed an association of the variant of the CDKAL1 locus
(rs7756992, G allele) with an increased level of fasting
glucose (β=0.009, 95% CI 0.002, 0.02, p=0.01). In
addition, variants at the T allele at TCF7L2 (transcription
factor 7 like 2), rs7903146 (β=0.007, 95% CI −0.0001,
0.01, p=0.05) and rs12255372 (β=0.01, 95% CI 0.004,
0.02, p=0.003) predicted higher fasting glucose levels. In
contrast, the CXCR4 locus (rs932206, T allele) was
associated with a lower level of fasting glucose (β=0.009,
95% CI −0.02, −0.0005, p=0.04), while we found
association of ADAM30 (rs2641348, G allele) (β=−0.05,
95% CI −0.10, −0.01, p=0.01) and the CDKN2A/B locus
(rs10811661, C allele) (β=−0.05, 95% CI −0.11, −0.004,
p=0.03) with reduced beta cell function.
Association analysis with type 2 diabetes In the present
study, of the 31 SNPs tested for association with type 2
diabetes (ESM Table 2), only a variant in the THADA locus
(rs7578597) was found to be associated with OR 1.5 (95%
CI 1.04, 2.22, p=0.03) and this association remained
significant even after adjustment for BMI. The remaining
SNPs in this study had estimated ORs of 1.1 or less (ESM
Table 1 Characteristics of participants in the Indian Migration Study
Characteristic Participants with diabetes Participants without diabetes p value
a (t test) Total participants
Sample size 635* 5,056 – 6,178
Men (%) 61.6 57.5 – 57.9
Age (years) 47.7±7.2 40.0±10.3 <0.0001 40.8±10.3
Age at diagnosis (years) 43.2±7.3 –– –
BMI (kg/m
2) 26.2±4.0 23.5±4.4 <0.0001 23.8±4.5
Fasting glucose (mmol/l) 7.8±3.1 5.0±0.6 <0.0001 5.3±1.4
Fasting insulin (pmol/l) 71.7±87.8 53.0±106.4 <0.0001 54.7±101.1
HOMA-β 57.6±49.9 88.8±60.2 <0.0001 85.6±59.9
HOMA-IR 1.49±2.05 0.95±0.95 <0.0001 1.0±1.12
Values are presented as mean±SD
aAmong 635 individuals, 487 belonged to pairs discordant for diabetes, and 148 individuals from pairs concordant for diabetes (i.e. 74 pairs)
(total number of pairs discordant and concordant for diabetes was 561 [487+74])
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Diabetologia (2012) 55:349–357 353Table 2) and we had insufficient power (because of the
population-based design) to detect such a low effect size.
After applying corrections for 31 SNPs (p<0.002 using
the false discovery rate), we did not find any significant
association with the studied phenotypes (fasting glucose,
fasting insulin, HOMA-IR, HOMA-β). For comparison, we
performed an additional analysis using Fulker’s between-
sib-pair model for total association with adjustment for a
limited number of population clusters identified by
STRUCTURE [30] (see ESM Fig. 1), but these results did
not differ appreciably from the within-family association.
Discussion
We report associations of ADAM30 and CDKN2A/B with
fasting insulin levels, HOMA-IR and HOMA-β in India.
Further, we report the associations of TCF-2 and NOTCH2
with fasting insulin level, and TCF-2 with HOMA-IR. We
also detected that CXCR4, CDKAL1 and TCF7L2 variants
influence fasting glucose levels in the study population. In
addition, we found the association of THADA with type 2
diabetes in the Indian population. The consistency of
detecting association of these regions in the Indian
population shows the importance of GWAS signals in
quantifying the effects of type 2 diabetes.
In order to understand the mechanisms involved in beta
cell function and glucose homeostasis, and to complement
the genetic analysis of type 2 diabetes, large-scale meta-
analysis of GWASs on continuous glycaemic phenotypes
has been performed in the last 2 years [4, 5, 31]. These
studies have found new genetic variants associated with
quantitative metabolic phenotypes and have increased our
understanding of the pathophysiology of type 2 diabetes. In
addition, several studies have also shown positive associ-
ations of genetic variants related to type 2 diabetes with the
continuous traits of this disease [32–34]. In India, few type
2 diabetes SNPs have been evaluated with quantitative
phenotypes, so the relevance of these SNPs for glycaemic
traits and their relation to the pathogenesis of type 2
diabetes is unclear for this population.
Of the 31 SNPs tested for association, we found that the
minor alleles of ADAM30 and CDKN2A/B variants predict
reduced fasting insulin, HOMA-IR and HOMA-β,
suggesting their role in insulin sensitivity and beta cell
dysfunction. Several studies did not find any association
of ADAM30 with quantitative traits related to type 2
diabetes [33–35], whereas for CDKN2A/B few studies
have shown evidence of impaired [36] and improved [37]
beta cell function. Similar to European population studies,
we also observed a strong LD between ADAM30 and
NOTCH2 [23] ,a n da na s s o c i a t i o no fNOTCH2 with lower
levels of fasting insulin [5]. Importantly, the variant,
rs2641348 in ADAM30 is a non-synonymous SNP
(L359P) and could be directly evaluated for functional
genomic studies to determine the mechanism regulating
insulin secretion and resistance [23]. Chauhan et al. [15]
studied CDKN2A/B in an Indian population but did not
observe an association with type-2-diabetes-related inter-
mediate traits. Only one small study from India has shown
an association of CDC123/CAMK1D with fasting insulin
levels in a Sikh population, but was unable to find any
evidence for CDKN2A/B and NOTCH2, probably because
of the low power of the study [14]. CDKN2A/B has a role
in pancreatic islets [38], and possibly influences insulin
secretion by decreasing beta cell mass [36].
Gudmundsson et al. [39] observed the protective role of
TCF-2 variant against type 2 diabetes among Europeans
and confirmed their findings in African and Chinese
populations; however, these observations could not be
replicated in an independent study in a Han Chinese
population [40, 41]. Notably, we have reported the
association of TCF-2 with higher levels of fasting insulin
and HOMA-IR, suggesting a role in insulin resistance.
CDKAL1 plays an important role in insulin secretion
from pancreatic beta cells [42]. In a recent large meta-
analysis of GWAS studies in non-diabetic individuals from
European populations, CDKAL1 was not associated with
any of the quantitative traits [5]. Chauhan et al. failed to
find any association of CDKAL1 with glycaemic traits in
Indians [15]. However, we found an association of the
CDKAL1 locus with increasing levels of fasting glucose, as
observed by Voight et al. [4]. Further, Cauchi et al. [43]
found an association of CXCR4 with type 2 diabetes in a
French population, and in the present study, we found an
association of the CXCR4 locus with increased levels of
fasting glucose, suggesting its role in glucose homeostasis.
We also replicated in our population an association of
TCF7L2 variants with high fasting glucose as reported by
Dupuis et al. [5] for Europeans. Recently, Chauhan et al.
[15] found associations of eight SNPs with type 2 diabetes
and also associations of PPARG and TCF7L2 with
HOMA-β. As reported elsewhere, TCF7L2 is also the
most promising gene harbouring common variations
associated with type 2 diabetes in India because of the
replication of results in all the studies [10–12]. However,
evidence for an association with fasting glucose was
positive only in the study by Chandak et al. [10], being
negative in most Indian studies [11, 14, 15]. As our study
has a large sample size and a design resistant to population
stratification, it could therefore be seen as providing
strong evidence in support of the role of TCF7L2 in the
homeostasis of fasting glucose levels in India.
Despite having reasonable power, we could replicate
associations of only seven SNPs with various glycaemic
phenotypes. Though difficult to explain, it is possible that
354 Diabetologia (2012) 55:349–357the remaining 24 SNPs might not play any role in
influencing these continuous traits in Indians. An alterna-
tive, perhaps more likely, explanation is that the underlying
causal variant is less well tagged by these SNPs in the
Indian population owing to different allele frequencies and
the extent of LD compared with Europeans.
As observed in the meta-analysis of GWASs by Zeggini
et al. [23], we also demonstrated a strong effect (OR 1.5) of
a THADA variant in predisposition to type 2 diabetes in our
study population. This locus was previously studied among
an Asian Sikh population, but no significant results were
observed [14]. This variant of THADA (rs7578597) results
in a missense mutation (T1187A) [23, 44] and is also
known to lower measures of beta cell function [34], and
hence it is a likely causal variant. The association of
THADAwith type 2 diabetes remained significant even after
adjustment for BMI, suggesting an independent effect of
the variant in predisposition to type 2 diabetes (ESM
Table 2). In addition to low power for type 2 diabetes as a
binary trait in our study, the lack of association of other
SNPs may reflect their low effect sizes in this population as
our sample estimates were 1.1 or lower. For instance, the
loci FTO, NGN3 (also known as NEUROG3), TSPAN8 (p
value>0.05) could present false negative values because of
the sample sizes available (ESM Table 2).
In addition, while comparing the effect sizes for type 2
diabetes and its related quantitative traits with Europeans
(see ESM Tables 1 and 3), we did not find any evidence
that the risk alleles from our Indian population were acting
in the same direction as in the European population (see
ESM Table 7). This suggests that further associations would
have been present in our sample but failed to reach
conventional levels of significance.
The major strengths of our study are the research design
and the high number of SNPs associated with type 2 diabetes
examined. In the Indian context, this is probably the largest
study investigating the effect of 31 genetic variants on various
intermediate traits predictive of type 2 diabetes. As the
participants came from different parts of India, we can claim
good representation of the Indian population and at the same
time have been able to control for population stratification
because of the model of sib-pair analysis. The present study is
the first to report the associations of ADAM30, NOTCH2,
CDKN2A/B and TCF-2 with various quantitative glycaemic
traits in an Indian population. The associations of CDKAL
and CXCR4 with fasting glucose in India are also observed
for the first time in our study. We replicated the strong effects
of THADA in predisposition of type 2 diabetes in this
Indian population. Furthermore, the high level of
population heterogeneity as described by Reich et al.
[16], population stratification and small sample sizes have
plagued case–control-based genetic association studies by
providing spurious associations and inconsistent results of
replication studies. In this challenging situation, the
present study has shown the benefit of a family-based
design for conducting genetic epidemiological studies in
India. The major limitation of our study was that, because
of the cohort design, we had limited power for analysing
binary traits and hence could not replicate published
results for the majority of genes associated with type 2
diabetes. Although correction for multiple testing is not
required for variants that already have strong priors of
association with type 2 diabetes, the possibility exists that
some of our weaker associations may represent false-
positive findings.
In conclusion, using a large sample of sib pairs, we
validated the association of seven type-2-diabetes-related
loci with various continuous glycaemic traits in the Indian
population. We also validated the strong association of
THADA with type 2 diabetes in our study population.
Furthermore, in the presence of a high level of population
heterogeneity and substructure, we have also provided
evidence of the utility of the sib-pair design for conducting
genetic epidemiological studies for late-onset complex
diseases in the Indian population.
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